Carvacrol, a food-additive, provides neuroprotection on focal cerebral ischemia/reperfusion injury in mice

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Yu, Hailong ^a,b   Zhang, Zeng Li ^b   Chen, Jing ^a,b   Pei, Aijie ^b   Hua, Fang ^c   Qian, Xuanchen ^a,b   He, Jinjiang ^b   Liu, Chun Feng ^a,b   Xu, Xingshun ^a,b  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARVACROL; CASPASE 3; PROTEIN KINASE B; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CASP3 PROTEIN, MOUSE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; FOOD ADDITIVE; MORPHOLINE DERIVATIVE; NEUROPROTECTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; TERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; TREATMENT RESPONSE; ANIMAL; APOPTOSIS; CEREBRAL ARTERY DISEASE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; NERVE CELL; PATHOLOGY; SIGNAL TRANSDUCTION;

MUS; RATTUS;

ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; CASPASE 3; CHROMONES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FOOD ADDITIVES; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED ICR; MONOTERPENES; MORPHOLINES; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84863371848     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033584     Document Type: Article

References (40)

1. Virmani R, Ladich ER, Burke AP, Kolodgie FD, (2006) Histopathology of carotid atherosclerotic disease. Neurosurgery 59: S219-227; discussion S213-213.
2. Sahota P, Savitz SI, (2011) Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeutics 8: 434-451.
3. Brouns R, De Deyn PP, (2009) The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 111: 483-495.
4. Meloni BP, Meade AJ, Kitikomolsuk D, Knuckey NW, (2011) Characterisation of neuronal cell death in acute and delayed in vitro ischemia (oxygen-glucose deprivation) models. J Neurosci Methods 195: 67-74.
5. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, et al. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1: 112-119.
6. Auriel E, Bornstein NM, (2010) Neuroprotection in acute ischemic stroke-current status. J Cell Mol Med 14: 2200-2202.
7. Ultee A, Kets EP, Smid EJ, (1999) Mechanisms of action of carvacrol on the food-borne pathogen Bacillus cereus. Appl Environ Microbiol 65: 4606-4610.
8. Garcia-Garcia R, Lopez-Malo A, Palou E, (2011) Bactericidal action of binary and ternary mixtures of carvacrol, thymol, and eugenol against Listeria innocua. J Food Sci 76: M95-100.
9. Ahmad A, Khan A, Akhtar F, Yousuf S, Xess I, et al. (2011) Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur J Clin Microbiol Infect Dis 30: 41-50.
10. Dambolena JS, Zygadlo JA, Rubinstein HR, (2011) Antifumonisin activity of natural phenolic compounds A structure-property-activity relationship study. Int J Food Microbiol 145: 140-146.
11. Tang X, Chen S, Wang L, (2011) Purification and identification of carvacrol from the root of Stellera chamaejasme and research on its insecticidal activity. Nat Prod Res 25: 320-325.
12. Jayakumar S, Madankumar A, Asokkumar S, Raghunandhakumar S, Gokula dhas K, et al. (2012) Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats. Mol Cell Biochem 360: 51-60.
13. Arunasree KM, (2010) Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231. Phytomedicine 17: 581-588.
14. Orhan I, Kartal M, Kan Y, Sener B, (2008) Activity of essential oils and individual components against acetyl- and butyrylcholinesterase. Z Naturforsch C 63: 547-553.
15. Jukic M, Politeo O, Maksimovic M, Milos M, (2007) In vitro acetylcholinesterase inhibitory properties of thymol, carvacrol and their derivatives thymoquinone and thymohydroquinone. Phytother Res 21: 259-261.
16. Kaufmann D, Dogra AK, Wink M, (2011) Myrtenal inhibits acetylcholinesterase, a known Alzheimer target. J Pharm Pharmacol 63: 1368-1371.
17. Melo FH, Moura BA, de Sousa DP, de Vasconcelos SM, Macedo DS, et al. (2011) Antidepressant-like effect of carvacrol (5-Isopropyl-2-methylphenol) in mice: involvement of dopaminergic system. Fundam Clin Pharmacol 25: 362-367.
18. Canbek M, Uyanoglu M, Bayramoglu G, Senturk H, Erkasap N, et al. (2008) Effects of carvacrol on defects of ischemia-reperfusion in the rat liver. Phytomedicine 15: 447-452.
19. Xu X, Chua CC, Gao J, Hamdy RC, Chua BH, (2006) Humanin is a novel neuroprotective agent against stroke. Stroke 37: 2613-2619.
20. Xu X, Chua KW, Chua CC, Liu CF, Hamdy RC, et al. (2010) Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain Res 1355: 189-194.
21. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, et al. (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10: 290-293.
22. Xu X, Chua CC, Gao J, Chua KW, Wang H, et al. (2008) Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway. Brain Res 1227: 12-18.
23. Guimaraes AG, Xavier MA, de Santana MT, Camargo EA, Santos CA, et al. (2011) Carvacrol attenuates mechanical hypernociception and inflammatory response. Naunyn Schmiedebergs Arch Pharmacol.
24. Coimbra M, Crielaard BJ, Storm G, Schiffelers RM, (2011) Critical factors in the development of tumor-targeted anti-inflammatory nanomedicines. J Control Release.
25. Wieten L, van der Zee R, Spiering R, Wagenaar-Hilbers J, van Kooten P, et al. (2010) A novel heat-shock protein coinducer boosts stress protein Hsp70 to activate T cell regulation of inflammation in autoimmune arthritis. Arthritis Rheum 62: 1026-1035.
26. Cho S, Choi Y, Park S, Park T, (2012) Carvacrol prevents diet-induced obesity by modulating gene expressions involved in adipogenesis and inflammation in mice fed with high-fat diet. J Nutr Biochem 23: 192-201.
27. Trabace L, Zotti M, Morgese MG, Tucci P, Colaianna M, et al. (2011) Estrous cycle affects the neurochemical and neurobehavioral profile of carvacrol-treated female rats. Toxicol Appl Pharmacol 255: 169-175.
28. Savelev SU, Okello EJ, Perry EK, (2004) Butyryl- and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituents. Phytother Res 18: 315-324.
29. Melo FH, Venancio ET, de Sousa DP, de Franca Fonteles MM, de Vasconcelos SM, et al. (2010) Anxiolytic-like effect of Carvacrol (5-isopropyl-2-methylphenol) in mice: involvement with GABAergic transmission. Fundam Clin Pharmacol 24: 437-443.
30. Boskabady MH, Jafari Z, Pouraboli I, (2011) The effect of carvacrol on muscarinic receptors of guinea-pig tracheal chains. Phytother Res 25: 530-535.
31. Parnas M, Peters M, Dadon D, Lev S, Vertkin I, et al. (2009) Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels. Cell Calcium 45: 300-309.
32. Yin QH, Yan FX, Zu XY, Wu YH, Wu XP, et al. (2012) Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2. Cytotechnology 64: 43-51.
33. Hotta M, Nakata R, Katsukawa M, Hori K, Takahashi S, et al. (2010) Carvacrol, a component of thyme oil, activates PPARalpha and gamma and suppresses COX-2 expression. J Lipid Res 51: 132-139.
34. Lee J, Jung E, Yu H, Kim Y, Ha J, et al. (2008) Mechanisms of carvacrol-induced expression of type I collagen gene. J Dermatol Sci 52: 160-169.
35. Mullonkal CJ, Toledo-Pereyra LH, (2007) Akt in ischemia and reperfusion. J Invest Surg 20: 195-203.
36. Zhao H, Sapolsky RM, Steinberg GK, (2006) Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 34: 249-270.
37. Amiri H, (2012) Essential oils composition and antioxidant properties of three thymus species. Evid Based Complement Alternat Med 2012: 728065.
38. Guimaraes AG, Oliveira GF, Melo MS, Cavalcanti SC, Antoniolli AR, et al. (2010) Bioassay-guided evaluation of antioxidant and antinociceptive activities of carvacrol. Basic Clin Pharmacol Toxicol 107: 949-957.
39. Andersen A, (2006) Final report on the safety assessment of sodium p-chloro-m-cresol, p-chloro-m-cresol, chlorothymol, mixed cresols, m-cresol, o-cresol, p-cresol, isopropyl cresols, thymol, o-cymen-5-ol, and carvacrol. Int J Toxicol 25 (Suppl 1): 29-127.
40. Nostro A, Papalia T, (2011) Antimicrobial Activity of Carvacrol: Current Progress and Future Prospectives. Recent Pat Antiinfect Drug Discov.